Tacrine for Alzheimer’s Disease: Costs and Benefits

David Knopman

doi:10.2165/00019053-199507040-00001

Tacrine for Alzheimer’s Disease: Costs and Benefits

David Knopman

Neurology

Research output: Contribution to journal › Editorial › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	275-279
Number of pages	5
Journal	PharmacoEconomics
Volume	7
Issue number	4
DOIs	https://doi.org/10.2165/00019053-199507040-00001
State	Published - Apr 1995

ASJC Scopus subject areas

Pharmacology
Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.2165/00019053-199507040-00001

Cite this

@article{ce9ad5aba61447bbb5db788deb231eaa,

title = "Tacrine for Alzheimer{\textquoteright}s Disease: Costs and Benefits",

author = "David Knopman",

year = "1995",

month = apr,

doi = "10.2165/00019053-199507040-00001",

language = "English (US)",

volume = "7",

pages = "275--279",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "4",

}

TY - JOUR

T1 - Tacrine for Alzheimer’s Disease

T2 - Costs and Benefits

AU - Knopman, David

PY - 1995/4

Y1 - 1995/4

UR - http://www.scopus.com/inward/record.url?scp=0028932651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028932651&partnerID=8YFLogxK

U2 - 10.2165/00019053-199507040-00001

DO - 10.2165/00019053-199507040-00001

M3 - Editorial

C2 - 10172459

AN - SCOPUS:0028932651

SN - 1170-7690

VL - 7

SP - 275

EP - 279

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 4

ER -

Tacrine for Alzheimer’s Disease: Costs and Benefits

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this